BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29064084)

  • 1. Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study.
    Rohde C; Polcwiartek C; Kragholm K; Ebdrup BH; Siskind D; Nielsen J
    Acta Psychiatr Scand; 2018 Jan; 137(1):47-53. PubMed ID: 29064084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.
    Wehmeier PM; Heiser P; Remschmidt H
    J Clin Pharm Ther; 2005 Feb; 30(1):91-6. PubMed ID: 15659009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.
    Reinders J; Parsonage W; Lange D; Potter JM; Plever S
    Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine.
    Wehmeier PM; Schüler-Springorum M; Heiser P; Remschmidt H
    J Child Adolesc Psychopharmacol; 2004; 14(2):267-71. PubMed ID: 15319023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].
    Kamphuis H; Arends J; Timmerman L; van Marle J; Kappert J
    Tijdschr Psychiatr; 2010; 52(4):223-33. PubMed ID: 20503163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
    Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
    Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Schulte PF
    Tijdschr Psychiatr; 2011; 53(3):193-4. PubMed ID: 21404176
    [No Abstract]   [Full Text] [Related]  

  • 8. Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposure.
    Lee J; Powell V; Remington G
    Schizophr Res; 2014 Aug; 157(1-3):134-6. PubMed ID: 24906221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P; Lapitskaya Y; Shaikh A; Nielsen J
    Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoring.
    Anıl Yağcıoğlu AE; Ertuğrul A; Karakaşlı AA; Ağaoğlu E; Ak S; Karahan S; Yazıcı MK
    Psychiatry Res; 2019 Sep; 279():90-97. PubMed ID: 31362146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.
    Youssef DL; Narayanan P; Gill N
    Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Cohen D
    Tijdschr Psychiatr; 2010; 52(10):727-8; author reply 728-9. PubMed ID: 20931487
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocarditis and cardiomyopathy associated with clozapine.
    Kilian JG; Kerr K; Lawrence C; Celermajer DS
    Lancet; 1999 Nov; 354(9193):1841-5. PubMed ID: 10584719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
    Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
    Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
    Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
    Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort.
    Bellissima BL; Vara A; Helsby N; Garavan F; Tingle MD
    Psychiatry Res; 2021 May; 299():113873. PubMed ID: 33799127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience.
    Murch S; Tran N; Liew D; Petrakis M; Prior D; Castle D
    Australas Psychiatry; 2013 Jun; 21(3):258-61. PubMed ID: 23439546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
    Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
    Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse cardiac effects associated with clozapine.
    Merrill DB; Dec GW; Goff DC
    J Clin Psychopharmacol; 2005 Feb; 25(1):32-41. PubMed ID: 15643098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.